MAPT and Alzheimer disease: Three CSF biomarkers in particular, total tau (t-tau), phosphorylated tau (p-tau) and amyloid beta 42 (Aβ42), are believed to have high diagnostic accuracy for early AD diagnosis and have been used as research criteria for the diagnosis of AD [1–3].